Biotech · Private company
Guardant Health, Inc.
Track this companyFree. Adds Guardant Health, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials169 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Decision Counseling SessionColo-rectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Guardant RevealBladder CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Guardant360Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Guardant360 testAdvanced Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Low-dose CT scanLung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Shield Blood Test for colo-rectal cancer ScreeningColo-rectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- Guardant Shield Colorectal Cancer ScreeningNA · ACTIVE_NOT_RECRUITING · started Jul 22, 2026ClinicalTrials.gov NCT07436637 · fetched Nov 12, 2026
- Decision Counseling and Follow-up for Shield+ PatientsNOT_YET_RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07620535 · fetched Nov 12, 2026
- Shield Post-Approval Study ProtocolRECRUITING · started Jul 14, 2025ClinicalTrials.gov NCT06880055 · fetched Nov 12, 2026
- Understanding Patient Preference on Colorectal Cancer Screening Options-PSUCOMPLETED · started Sep 16, 2024ClinicalTrials.gov NCT06444542 · fetched Nov 12, 2026
- SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuationRECRUITING · started Oct 25, 2023ClinicalTrials.gov NCT05935384 · fetched Nov 12, 2026
- Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice HighlandsNA · COMPLETED · started Oct 12, 2023ClinicalTrials.gov NCT06119425 · fetched Nov 12, 2026
- Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")UNKNOWN · started Feb 1, 2023ClinicalTrials.gov NCT05703243 · fetched Nov 12, 2026
- Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved PatientsCOMPLETED · started Dec 23, 2022ClinicalTrials.gov NCT05716477 · fetched Nov 12, 2026
- Screening for High Frequency Malignant DiseaseACTIVE_NOT_RECRUITING · started Jan 13, 2022ClinicalTrials.gov NCT05117840 · fetched Nov 12, 2026
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRECRUITING · started Sep 7, 2021ClinicalTrials.gov NCT05059444 · fetched Nov 12, 2026
- Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast CancerCOMPLETED · started Jul 2, 2020ClinicalTrials.gov NCT04436393 · fetched Nov 12, 2026
- Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung CancersPHASE2 · RECRUITING · started May 28, 2020ClinicalTrials.gov NCT04410796 · fetched Nov 12, 2026
- Evaluation of the ctDNA LUNAR Test in an Average Patient Screening EpisodeACTIVE_NOT_RECRUITING · started Oct 8, 2019ClinicalTrials.gov NCT04136002 · fetched Nov 12, 2026
- Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical RecordsCOMPLETED · started Apr 30, 2019ClinicalTrials.gov NCT03625557 · fetched Nov 12, 2026
- Registry of Guardant360® Use and Outcomes In People With Advanced CancerTERMINATED · started Apr 6, 2018ClinicalTrials.gov NCT03477474 · fetched Nov 12, 2026
- Biomarkers for Risk Stratification in Lung CancerRECRUITING · started Dec 17, 2017ClinicalTrials.gov NCT03774758 · fetched Nov 12, 2026